Top

Social Psychiatry and Psychiatric Epidemiology

Published in:

01-05-2010 | Original Paper

Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders

Authors: Malin Alenius, Margareta Hammarlund-Udenaes, Per Hartvig, Leif Lindström

Published in: Social Psychiatry and Psychiatric Epidemiology | Issue 5/2010

Abstract

Background

Patients with psychotic symptoms often respond poorly to treatment. Outcomes can be affected by biological, physiological and psychological factors according to the vulnerability–stress model. The patient’s coping strategies and beliefs have been correlated with outcomes.

Objectives

To investigate the knowledge and insight in relation to treatment response.

Methods

A naturalistic study was performed using patient interviews and information gathered from patient drug charts. Apart from the rating scales used for classification of treatment response (CANSEPT method), the SPKS knowledge of illness and drugs rating scale was utilized.

Results

In the group of patients in functional remission (FR; n = 38), 37% had insight into their illness as compared to 10% among those not in functional remission (non-FR; n = 78; P < 0.01). As much as 23% of the non-FR group had no strategy for responding to warning signs versus 8% in the FR group (P < 0.05).

Conclusions

Better treatment outcomes appear to be associated with better insight into illness, higher knowledge of warning signs and better coping strategies.

Alenius M, Hammarlund-Udenaes M, Hartvig P, Sundquist S,Lindström L (2009) Treatment response in psychotic patients classified according to social and clinical needs, drug side effects and previous treatment: a method to identify functional remission. Compr Psychiatry (In Press). doi:10.1016/j.comppsych.2008.1011.1001

Andres K, Pfammatter M, Fries A, Brenner HD (2003) The significance of coping as a therapeutic variable for the outcome of psychological therapy in schizophrenia. Eur Psychiatry 18(4):149–154CrossRefPubMed

Arvidsson H (2003) Test–retest reliability of the Camberwell Assessment of Need (CAN). Nord J Psychiatry 57(4):279–283CrossRefPubMed

Beiser M, Iacono WG (1990) An update on the epidemiology of schizophrenia. Can J Psychiatry 35(8):657–668PubMed

Borell P, Orhagen T, dÉlia G (1995) Vad vet patienter med schizofreni om sin sjukdom? Scand J Behaviour Therapy 24(2–3):63–74

Carter DM, Mackinnon A, Copolov DL (1996) Patients’ strategies for coping with auditory hallucinations. J Nerv Ment Dis 184(3):159–164CrossRefPubMed

Clary C, Dever A, Schweizer E (1992) Psychiatric inpatients’ knowledge of medication at hospital discharge. Hosp Community Psychiatry 43(2):140–144PubMed

Cooke M, Peters E, Fannon D, Anilkumar AP, Aasen I, Kuipers E, Kumari V (2007) Insight, distress and coping styles in schizophrenia. Schizophr Res 94(1–3):12–22CrossRefPubMed

Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C (2005) Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62(7):717–724CrossRefPubMed

10.

de Hert M, Wampers M, Thys E, Wieselgren I, Lindström E, Peuskens J (2002) Validation study of PECC (psychosis evaluation tool for common use by caregivers): interscale validity and inter-rater reliability. Int J Psych Clin Pract 6:135–140CrossRef

11.

Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW (2007) Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry 68(1):81–86CrossRefPubMed

12.

Eccles R (2007) The power of the placebo. Curr Allergy Asthma Rep 7(2):100–104CrossRefPubMed

13.

Falloon I, Fadden G, Borell P, Kärräng L, Ivarsson B,Malm U (1997) Integrerad psykiatri. Psykologia ISBN 91-630-5438-8(1-349

14.

Falloon IR (1988) Expressed emotion: current status. Psychol Med 18(2):269–274CrossRefPubMed

15.

Farhall J, Greenwood KM, Jackson HJ (2007) Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions. Clin Psychol Rev 27(4):476–493CrossRefPubMed

16.

Geers AL, Kosbab K, Helfer SG, Weiland PE, Wellman JA (2007) Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res 62(5):563–570CrossRefPubMed

17.

Geller JL (1982) State hospital patients and their medication—do they know what they take? Am J Psychiatry 139(5):611–615PubMed

18.

Hansson L, Bjorkman T, Svensson B (1995) The assessment of needs in psychiatric patients. Interrater reliability of the Swedish version of the Camberwell Assessment of Needs instrument and results from a cross-sectional study. Acta Psychiatr Scand 92(4):285–293CrossRefPubMed

19.

Harrow M, Sands JR, Silverstein ML, Goldberg JF (1997) Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr Bull 23(2):287–303PubMed

20.

Heila H, Haukka J, Suvisaari J, Lonnqvist J (2005) Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 35(5):725–732CrossRefPubMed

21.

Johansen O, Brox J, Flaten MA (2003) Placebo and nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med 65(5):786–790CrossRefPubMed

22.

Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45(9):789–796PubMed

23.

Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ (2006) Medication adherence in schizophrenia: exploring patients’, carers’ and professionals’ views. Schizophr Bull 32(4):786–794CrossRefPubMed

24.

Kingdon D, Gibson A, Kinoshita Y, Turkington D, Rathod S, Morrison A (2008) Acceptable terminology and subgroups in schizophrenia: an exploratory study. Soc Psychiatry Psychiatr Epidemiol 43(3):239–243CrossRefPubMed

25.

Ko NY, Yeh ML, Hsu ST, Chung HH, Yen CF (2006) Investigation of insight formation using narrative analyses of people with schizophrenia in remission. J Nerv Ment Dis 194(2):124–127CrossRefPubMed

26.

Lee PW, Lieh-Mak F, Yu KK, Spinks JA (1993) Coping strategies of schizophrenic patients and their relationship to outcome. Br J Psychiatry 163:177–182CrossRefPubMed

27.

Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F (2007) Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res 94(1–3):23–28CrossRefPubMed

28.

Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU Side Effect Rating Scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1–100CrossRefPubMed

29.

Link J, Haggard R, Kelly K, Forrer D (2006) Placebo/nocebo symptom reporting in a sham herbal supplement trial. Eval Health Prof 29(4):394–406CrossRefPubMed

30.

Macpherson R, Double DB, Rowlands RP, Harrison DM (1993) Long-term psychiatric patients’ understanding of neuroleptic medication. Hosp Community Psychiatry 44(1):71–73PubMed

31.

Nes LS, Segerstrom SC (2006) Dispositional optimism and coping: a meta-analytic review. Pers Soc Psychol Rev 10(3):235–251CrossRefPubMed

32.

Nuechterlein KH, Dawson ME (1984) A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 10(2):300–312PubMed

33.

Osby U, Correia N, Brandt L, Ekbom A, Sparen P (2000) Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res 45(1–2):21–28CrossRefPubMed

34.

Peuskens J (1999) The evolving definition of treatment resistance. J Clin Psychiatry 60(Suppl 12):4–8PubMed

35.

Phelan M, Slade M, Thornicroft G, Dunn G, Holloway F, Wykes T, Strathdee G, Loftus L, McCrone P, Hayward P (1995) The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry 167(5):589–595CrossRefPubMed

36.

Saeedi H, Addington J, Addington D (2007) The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up. Schizophr Res 89(1–3):123–128CrossRefPubMed

37.

Sharma T, Antonova L (2003) Cognitive function in schizophrenia. deficits, functional consequences, and future treatment. Psychiatr Clin North Am 26(1):25–40CrossRefPubMed

38.

Wieselgren IM, Lindstrom LH (1996) A prospective 1–5-year outcome study in first-admitted and readmitted schizophrenic patients: relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiatr Scand 93(1):9–19CrossRefPubMed

39.

Zubin J, Spring B (1977) Vulnerability: a new view of schizophrenia. J Abnorm Psychol 86(2):103–126CrossRefPubMed

40.

Zubin J, Steinhauer SR, Day R, van Kammen DP (1985) Schizophrenia at the crossroads: a blueprint for the 80s. Compr Psychiatry 26(3):217–240CrossRefPubMed

Title: Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders
Authors: Malin Alenius
Margareta Hammarlund-Udenaes
Per Hartvig
Leif Lindström
Publication date: 01-05-2010
Publisher: Springer-Verlag
Published in: Social Psychiatry and Psychiatric Epidemiology / Issue 5/2010
Print ISSN: 0933-7954
Electronic ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-009-0096-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders

Abstract

Background

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2010

Trends in hospital admissions for eating disorders in a country undergoing a socio-cultural transition, the Czech Republic 1981–2005

The mental health of young children with intellectual disabilities or borderline intellectual functioning

Common mental disorder and associated factors amongst women with young infants in rural Malawi

The interaction of obesity and psychological distress on disability

Predictors of suicidality in depressive spectrum disorders in the general population: results of the Netherlands Mental Health Survey and Incidence Study

Behavioral emergencies in India: a population based epidemiological study